Plasma advanced oxidative protein products are associated with anti-oxidative stress pathway genes and malaria in a longitudinal cohort

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Zhang, Guicheng ^a,f   Skorokhod, Oleksii A ^b   Khoo, Siew Kim ^a   Aguilar, Ruth ^c,d,e   Wiertsema, Selma ^a   Nhabomba, Augusto J ^c   Marrocco, Tiziana ^b   McNamara Smith, Michelle ^a   Manaca, Maria Nelia ^c   Barbosa, Arnoldo ^c   Quintó, Llorenç ^d,e   Hayden, Catherine M ^a   Goldblatt, Jack ^a   Guinovart, Caterina ^c,d,e   Alonso, Pedro L ^c,d,e   Dobaño, Carlota ^c,d,e   Schwarzer, Evelin ^b   Lesouëf, Peter N ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF TURIN   (Italy)

^c Manhiça Health Research Center   (Mozambique)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f CURTIN UNIVERSITY   (Australia)

Author keywords

Anaemia; AOPP; Malaria; Oxidative pathway genes; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; MANGANESE SUPEROXIDE DISMUTASE;

ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ENZYME BLOOD LEVEL; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HOMOZYGOTE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALARIA; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADVANCED OXIDATION PROTEIN PRODUCTS; ANEMIA; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; MOZAMBIQUE; OXIDATIVE STRESS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC;

EID: 84899090621     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-134     Document Type: Article

References (51)

1. Antioxidant defense in plasmodium falciparum-data mining of the transcriptome. Bozdech Z, Ginsburg H, Malar J 2004 3 23 10.1186/1475-2875-3-23 15245577 (Pubitemid 39319750)
2. Effect of superoxide anions on red blood cell rheologic properties. Baskurt OK, Temiz A, Meiselman HJ, Free Radic Biol Med 1998 24 102 110 10.1016/S0891-5849(97)00169-X 9436619 (Pubitemid 28006441)
3. HNE produced by the malaria parasite Plasmodium falciparum generates HNE-protein adducts and decreases erythrocyte deformability. Skorokhod A, Schwarzer E, Gremo G, Arese P, Redox Rep 2007 12 73 75 10.1179/135100007X162284 17263914 (Pubitemid 46210360)
4. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H, Int J Parasitol 2004 34 163 189 10.1016/j.ijpara.2003.09.011 15037104 (Pubitemid 38229822)
5. In utero smoke exposure and role of maternal and infant glutathione s-transferase genes on airway responsiveness and lung function in infancy. Murdzoska J, Devadason SG, Khoo SK, Landau LI, Young S, Goldblatt J, Zhang G, Le Souef PN, Hayden CM, Am J Respir Crit Care Med 2010 181 64 71 10.1164/rccm.200812-1887OC 19850945
6. The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma. Schultz EN, Devadason SG, Khoo SK, Zhang G, Bizzintino JA, Martin AC, Goldblatt J, Laing IA, Le Souef PN, Hayden CM, J Asthma 2010 47 1049 1056 20858151
7. Common genotypic polymorphisms in glutathione S-transferases in mild and severe falciparum malaria in Tanzanian children. Kavishe RA, Bousema T, Shekalaghe SA, Sauerwein RW, Mosha FW, van der Ven AJ, Russel FG, Koenderink JB, Am J Trop Med Hyg 2009 81 363 365 19635899
8. Severe Plasmodium falciparum malaria in Cameroon: associated with the glutathione S-transferase M1 null genotype. Kavishe RA, Koenderink JB, McCall MB, Peters WH, Mulder B, Hermsen CC, Sauerwein RW, Russel FG, Van der Ven AJ, Am J Trop Med Hyg 2006 75 827 829 17123972 (Pubitemid 351627525)
9. Cytochrome P4501A1 and glutathione S transferase gene polymorphisms in patients with aplastic anemia in India. Poonkuzhali B, Shaji RV, Salamun DE, George B, Srivastava A, Chandy M, Acta Haematol 2005 114 127 132 10.1159/000087885 16227674 (Pubitemid 41540334)
10. Glutathione-S-transferase genes and asthma phenotypes: a human genome epidemiology (HuGE) systematic review and meta-analysis including unpublished data. Minelli C, Granell R, Newson R, Rose-Zerilli MJ, Torrent M, Ring SM, Holloway JW, Shaheen SO, Henderson JA, Int J Epidemiol 2010 39 539 562 10.1093/ije/dyp337 20032267
11. Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review. Bentley AR, Emrani P, Cassano PA, Thorax 2008 63 956 961 10.1136/thx.2007.086199 18566111
12. Genetic links between diabetes mellitus and coronary atherosclerosis. Ordovas JM, Curr Atheroscler Rep 2007 9 204 210 10.1007/s11883-007-0020-9 18241614 (Pubitemid 47629068)
13. Glutathione S-transferases: an overview in cancer research. Di Pietro G, Magno LA, Rios-Santos F, Expert Opin Drug Metab Toxicol 2010 6 153 170 10.1517/17425250903427980 20078251
14. A GAG trinucleotide-repeat polymorphism in the gene for glutathione biosynthetic enzyme, GCLC, affects gene expression through translation. Nichenametla SN, Lazarus P, Richie JP Jr, FASEB J 2011 25 2180 2187 10.1096/fj.10-174011 21444626
15. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. Oliveira CP, Stefano JT, Cavaleiro AM, Zanella Fortes MA, Vieira SM, Rodrigues Lima VM, Santos TE, Santos VN, de Azevedo Salgado AL, Parise ER, Ferreira Alves VA, Carrilho FJ, Correa-Giannella ML, J Gastroenterol Hepatol 2010 25 357 361 10.1111/j.1440-1746.2009.06001.x 19817962
16. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Mendonca VR, Luz NF, Santos NJ, Borges VM, Goncalves MS, Andrade BB, Barral-Netto M, Infect Immun 2012 80 1445 1454 10.1128/IAI.05933-11 22290142
17. Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis. Mlakar SJ, Osredkar J, Prezelj J, Marc J, Menopause 2012 19 368 376 10.1097/gme.0b013e31822d5b10 22089180
18. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM, Nat Med 2007 13 703 710 10.1038/nm1586 17496899 (Pubitemid 46889755)
19. HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. Walther M, De Caul A, Aka P, Njie M, Amambua-Ngwa A, Walther B, Predazzi IM, Cunnington A, Deininger S, Takem EN, Ebonyi A, Weis S, Walton R, Rowland-Jones S, Sirugo G, Williams SM, Conway DJ, PLoS Pathog 2012 8 1002579 10.1371/journal.ppat.1002579 22438807
20. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B, Kidney Int 1996 49 1304 1313 10.1038/ki.1996.186 8731095 (Pubitemid 26166404)
21. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Selmeci L, Szekely M, Soos P, Seres L, Klinga N, Geiger A, Acsady G, Free Radic Res 2006 40 952 958 17015275 (Pubitemid 44480558)
22. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? Selmeci L, Free Radic Res 2011 45 1115 1123 10.3109/10715762.2011.602074 21740311
23. Are advanced oxidation protein products potential uremic toxins? Witko-Sarsat V, Gausson V, Descamps-Latscha B, Kidney Int Suppl 2003 63 11 S14 10.1046/j.1523-1755.63.s84.47.x
24. The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial. Guinovart C, Dobano C, Bassat Q, Nhabomba A, Quinto L, Manaca MN, Aguilar R, Rodriguez MH, Barbosa A, Aponte JJ, Mayor AG, Renom M, Moraleda C, Roberts DJ, Schwarzer E, Le Souef PN, Schofield L, Chitnis CE, Doolan DL, Alonso PL, PLoS One 2012 7 32362 10.1371/journal.pone.0032362 22412865
25. Efficacy of the RTS, S/AS02A vaccine against plasmodium falciparum infection and disease in young African children: randomised controlled trial. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitie MA, Dubovsky F, Menendez C, Tornieporth N, Ballou WR, Thompson R, Cohen J, Lancet 2004 364 1411 1420 10.1016/S0140-6736(04)17223-1 15488216 (Pubitemid 39370716)
26. Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children. Zhang G, Manaca MN, McNamara-Smith M, Mayor A, Nhabomba A, Berthoud TK, Khoo SK, Wiertsema S, Aguilar R, Barbosa A, Quinto L, Candelaria P, Schultz EN, Hayden CM, Goldblatt J, Guinovart C, Alonso PL, Lesouef PN, Dobano C, Infect Immun 2012 80 2316 2322 10.1128/IAI.00261-12 22566507
27. Blood oxidative stress markers and plasmodium falciparum malaria in non-immune African children. Aguilar R, Marrocco T, Skorokhod OA, Barbosa A, Nhabomba A, Manaca MN, Guinovart C, Quinto L, Arese P, Alonso PL, Dobano C, Schwarzer E, Br J Haematol 2014 164 438 450 10.1111/bjh.12636 24422726
28. SNP genotyping using the sequenom massarray iplex platform. Gabriel S, Ziaugra L, Tabbaa D, Curr Protoc Hum Genet 2009 Unit 2 Chapter 2 12 http://www.ncbi.nlm.nih.gov/pubmed/19170031
29. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, Descamps-Latscha B, J Immunol 1998 161 2524 2532 9725252 (Pubitemid 28397070)
30. Innate immunity in heart, lung and blood disease programs for genomic applications. https://regepi.bwh.harvard.edu/IIPGA2/
31. Serum levels of advanced oxidation protein products in response to allergen exposure in allergic rhinitis. Aksoy F, Yildirim YS, Veyseller B, Demirhan H, Ozturan O, Ear Nose Throat J 2012 91 32 E35
32. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children. Codoner-Franch P, Tavarez-Alonso S, Murria-Estal R, Tortajada-Girbes M, Simo-Jorda R, Alonso-Iglesias E, Nutr Metab Cardiovasc Dis 2012 22 237 243 10.1016/j.numecd.2010.06.002 20708392
33. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Krzystek-Korpacka M, Patryn E, Boehm D, Berdowska I, Zielinski B, Noczynska A, Clin Biochem 2008 41 943 949 10.1016/j.clinbiochem.2008.04.024 18501708
34. Enhanced formation of advanced oxidation protein products in IBD. Krzystek-Korpacka M, Neubauer K, Berdowska I, Boehm D, Zielinski B, Petryszyn P, Terlecki G, Paradowski L, Gamian A, Inflamm Bowel Dis 2008 14 794 802 10.1002/ibd.20383 18213700 (Pubitemid 351898064)
35. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, Zhang X, Arterioscler Thromb Vasc Biol 2006 26 1156 1162 10.1161/01.ATV.0000214960.85469.68 16497990 (Pubitemid 43732127)
36. Increased level of advanced oxidation protein products in patients with coronary artery disease. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M, Atherosclerosis 2002 162 221 225 10.1016/S0021-9150(01)00706-7 11947918 (Pubitemid 34327362)
37. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Alagozlu H, Gorgul A, Bilgihan A, Tuncer C, Unal S, Clin Res Hepatol Gastroenterol 2012 37 80 85 22572519
38. CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. Iwao Y, Nakajou K, Nagai R, Kitamura K, Anraku M, Maruyama T, Otagiri M, Am J Physiol Renal Physiol 2008 295 1871 F1880 10.1152/ajprenal.00013.2008 18971214
39. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study. Anraku M, Kitamura K, Shintomo R, Takeuchi K, Ikeda H, Nagano J, Ko T, Mera K, Tomita K, Otagiri M, Clin Biochem 2008 41 1168 1174 10.1016/j.clinbiochem.2008.07.007 18692036
40. Monitoring oxidative stress in acute-on-chronic liver failure by advanced oxidation protein products. Liu H, Han T, Tian J, Zhu ZY, Liu Y, Li Y, Xiao SX, Feng YY, Hepatol Res 2012 42 171 180 10.1111/j.1872-034X.2011.00911.x 22103276
41. The plasma concentration of advanced oxidation protein products and arterial stiffness in apparently healthy adults. Wykretowicz A, Adamska K, Krauze T, Guzik P, Szczepanik A, Rutkowska A, Wysoki H, Free Radic Res 2007 41 645 649 10.1080/10715760701236741 17516236 (Pubitemid 46845584)
42. The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Baskol G, Gumus K, Oner A, Arda H, Karakucuk S, Eur J Ophthalmol 2008 18 792 798 18850560
43. Advanced oxidation protein products: oxidative stress markers and mediators of inflammation in uremia. Witko-Sarsat V, Nguyen Khoa T, Jungers P, Drueke T, Descamps-Latscha B, Adv Nephrol Necker Hosp 1998 28 321 341 9889997
44. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels. Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A, Exp Clin Endocrinol Diabetes 2007 115 221 228 10.1055/s-2007-970574 17479437 (Pubitemid 46762248)
45. Chronic beryllium disease and glutathione biosynthesis genes. Bekris LM, Viernes HM, Farin FM, Maier LA, Kavanagh TJ, Takaro TK, J Occup Environ Med 2006 48 599 606 10.1097/01.jom.0000201845.02369.ba 16766924 (Pubitemid 43904251)
46. Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT. Berk M, Johansson S, Wray NR, Williams L, Olsson C, Haavik J, Bjerkeset O, J Affect Disord 2011 131 207 213 10.1016/j.jad.2010.12.019 21277635
47. Genetic variation in the glutathione synthesis pathway, air pollution, and children's lung function growth. Breton CV, Salam MT, Vora H, Gauderman WJ, Gilliland FD, Am J Respir Crit Care Med 2011 183 243 248 10.1164/rccm.201006- 0849OC 20802163
48. Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal. Skorokhod OA, Caione L, Marrocco T, Migliardi G, Barrera V, Arese P, Piacibello W, Schwarzer E, Blood 2010 116 4328 4337 10.1182/blood-2010-03-272781 20686121
49. Transfer of 4-hydroxynonenal from parasitized to non-parasitized erythrocytes in rosettes. Proposed role in severe malaria anemia. Uyoga S, Skorokhod OA, Opiyo M, Orori EN, Williams TN, Arese P, Schwarzer E, Br J Haematol 2012 157 116 124 10.1111/j.1365-2141.2011.09015.x 22352722
50. Inherited glutathione reductase deficiency and Plasmodium falciparum malaria-a case study. Gallo V, Schwarzer E, Rahlfs S, Schirmer RH, van Zwieten R, Roos D, Arese P, Becker K, PLoS One 2009 4 7303 10.1371/journal.pone.0007303 19806191
51. Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. Sambo MR, Trovoada MJ, Benchimol C, Quinhentos V, Goncalves L, Velosa R, Marques MI, Sepulveda N, Clark TG, Mustafa S, Wagner O, Coutinho A, Penha-Goncalves C, PLoS One 2010 5 11141 10.1371/journal.pone.0011141 20585394